Study in Polish Acromegalic Patients Treated With Somatuline Autogel
Study in Polish Acromegalic Patients Treated With Somatuline Autogel
The purpose of this study is to evaluate over the 24 month prospective follow up - in
 everyday clinical practice - resource utilization and effectiveness of the treatment of
 acromegalic patients in Poland with Somatuline Autogel 120 mg including extended injection
 intervals.
Inclusion Criteria:

 -  Adult patients with acromegaly treated for at least three injections with Somatuline
 Autogel 120 mg

 -  Subjects must be treated for acromegaly for at least 1 year, with medical treatment
 prior to inclusion. One year historical data must be available

 Exclusion Criteria:

 -  Active participation in any interventional or any other non-interventional acromegaly
 clinical study. Previous participation in observational / post-marketing study of
 other somatostatin analogue should not be an exclusion criteria